Concurrent Radiochemotherapy with Ifosfamide in Unresectable Stage III Non-Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 2296-5262|21|1|57-62

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.1, 1998-03, pp. : 57-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Concurrent Radiochemotherapy with Ifosfamide in Locally Advanced Unresectable Non-Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 2, 1998-06 ,pp. : 15-18

Karger

Access to resources Recommend Favorite

Ifosfamide in Non-Small Cell Lung Cancer

By  

Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 50-54

Karger

Access to resources Recommend Favorite

Treatment of Inoperable Stage III and IV Non-Small-Cell Lung Cancer: The ‘Average’Radiotherapist’s Point of View

By  

Oncology Research and Treatment, Vol. 24, Iss. 4, 2001-09 ,pp. : 333-339

Karger

Access to resources Recommend Favorite

A Phase II Study of the Docetaxel- Ifosfamide-Carboplatin Combination in Advanced Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. : 333-341

Karger

Access to resources Recommend Favorite

Ifosfamide in Small Cell Lung Cancer

By  

Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 46-49

Karger

Access to resources Recommend Favorite